/home/apy V itamin D is a fat-soluble vitamin obtained through food consumption as ergocalciferol (vitamin D2) and through synthesis in the skin after ultraviolet B exposure as cholecalciferol (vitamin D3). The prevalence of 25-hydroxyvitamin D (25(OH)D) deficiency in an Australian population ranges from 33% in summer months to 58% in late winter and spring months. 1 The common definition of vitamin D deficiency is a serum 25(OH)D concentration less than 50 nmol/l, where the risk of adverse bone effects is well established. Furthermore, the risk is stratified into mild, moderate and severe deficiency. The position statement detailing recommendations for management of vitamin D deficiency in adult bone health was released by the Medical Journal of Australia 2 and Royal College of Pathologists of Australasia. 3 The discovery of vitamin D receptors in extra-skeletal systems has increased interest in possible non-skeletal actions. Researchers have since reported associations between vitamin D levels and multiple body systems including, more recently, psychiatric conditions. 4 Vitamin D receptors are present throughout the brain, and vitamin D deficiency is associated with negative central nervous system effects in animal studies. 5 Despite the promising studies on extra-skeletal diseases, the outcomes are limited to associations prone to biases associated with observational data. To delineate between 25(OH)D concentrations and ill health, Autier and colleagues 6 analysed prospective and nested case-control studies where a range major health outcomes and physiological parameters related to disease risk or inflammatory status were included. The discrepancy between the observational and interventional studies analysed suggests that low 25(OH)D is a marker of ill health and The mean vitamin D level of those tested was 51.63 nmol/l. Of those that were tested, 18/37 (48.6%) were mildly to moderately deficient. There was a statistically significant difference in age and length of stay between those that were and were not tested for vitamin D levels, p-value <0.001 and 0.017, respectively. In addition, a simple linear regression indicated a weak association between length of stay and vitamin D levels. Conclusion: This audit highlights vitamin D screening inadequacy. More research is recommended to establish tangible benefits of supplementation, while local practice provides valuable data for education and policy purposes.
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Physical health inflammatory processes involved in disease occurrence and its clinical course, thus giving an insight into the high prevalence of low vitamin D status in the mental health population.
There are no current guidelines for routine screening within inpatient or outpatient psychiatric populations. To our knowledge, there have been no local studies examining the pathology test utilisation of 25(OH)D. Such findings, and research into subsequent cost impact and value to enable the development of vitamin D guidelines in this population, would be useful. Serum 25(OH)D levels are being measured more regularly as part of standard baseline investigations in the literature reviewed, and thus this audit will shed more information in an Australian regional tertiary hospital setting. The aim of this audit is to examine the utilisation of 25(OH)D testing within an inpatient psychiatric setting, including quantification of mean serum vitamin D levels of those tested, and exploring the characteristics of this group.
Method Study design
This study was a retrospective clinical audit of those admitted as inpatients to the mental health ward at a regional major referral and teaching hospital in New South Wales. In addition, patients were admitted during different seasons, from summer in 2014 to subsequent summer in 2015. There were 1432 subjects identified in this period; however, a sub-population of 303 subjects was selected at random using medical record numbers in ascending order. These numbers do not have any inherent ordering and only index admission was recorded if there were more than >1 admission. The medical records were reviewed and the database was populated by one of the authors. Eligible subjects were individuals aged ≥18 years; three patients were excluded due to long-term 
Statistical analysis
Descriptive analysis of the demographic and clinical characteristics of the study subjects including levels of vitamin D and percentage sufficiency and deficiency was performed. The Shapiro-Wilk test statistic was used to determine normality of continuous data with p ≥ 0.05 denoting an approximation of a normal distribution and p < 0.05 suggesting a non-normal distribution. If the data was normal, descriptive statistics were reported as a mean and standard deviation (SD), otherwise as a median and interquartile range (IQR). Furthermore, continuous data was tested using either an independent samples t-test or a Wilcoxon ranked-sum test as determined by normality. Categorical data was examined using chi-squared tests. A p-value of < 0.05 was considered significant. All statistical tests were performed using STATA (version 14.1).
Results
Charts from 300 patients were reviewed, and characteristics of the subjects are shown in Table 1 . The average age of the patients was 50 years; with a 51.7% male to 48.7% The number of inpatients who had a vitamin D determination during their admission was 37/300 (12.33%). The mean vitamin D level of those tested was 51.63 nmol/l, with a range of 12.7-127 nmol/l. Of those that were tested, 18/37 (48.6%) were mildly to moderately deficient; however, there were no statistically significant differences in age, length of stay or BMI between those sufficient and deficient.
A simple linear regression was performed to examine the influence of length of stay on vitamin D levels. However, this was found to be non-significant at p = 0.288 and explained little of the variance of the response variable (<1%). In addition, a Pearson's correlation indicated a marginal inverse correlation between length of stay and vitamin D level, r = −0.18 (see Figure 1 ).
Discussion
Utilisation of testing in the present audit was 37 of the 300 (12.33%) patients. This seems low compared with other psychiatric inpatient units where they have adopted routine screening practices on admission due to high rates of deficiency of vitamin D in general psychiatric inpatient settings. 7 Cross-sectional studies suggest that vitamin D insufficiency and deficiency is highly prevalent in inpatient and outpatient psychiatric populations worldwide. 8, 9 In an Australian psychiatric inpatient unit, Berk and colleagues 7 found that 58% of inpatients had insufficient levels of vitamin D and 11% were deficient. On average, this was 29% lower than levels in healthy controls. It is reasonably concluded in these papers that supplementation with vitamin D in deficiency is warranted as it is easily corrected, and the potentially important role in general physical and mental health far outweighs the risk of not correcting this recognised clinical condition. 10 Further studies would be encouraged to evaluate the effect of treatment of screen-detected vitamin D deficiency and the incidence of toxicity through supplementation. 11 The mean level of vitamin D in this study was 51.63 nmol/l (SD 25.38 nmol/l). This is above the threshold of 50 nmol/l (at the end of winter), thus not clinically low for the population tested. We note, however, while we have excluded patients with known vitamin D supplementation, there may be cases of supplementation not recorded due to long-term supplementation or other reasons for omittance in the records reviewed. Thus, the mean vitamin D level found in the present study may be falsely elevated.
The median BMI for those that had a BMI recorded was 28kg/m 2 , which is in the overweight range. The dietary patterns studied in samples with psychiatric disorders show poor diet quality. 12 There are limited food choices that contain vitamin D. It may be worthwhile to examine dietary intakes and sun exposure to determine whether low vitamin D level is a consequence of environmental causes related to psychiatric morbidity, or if it has a role in pathogenesis involving a common pathway. This observation is related to low levels of vitamin D being previously reported in patients with depression and schizophrenia. 13 This sample had a large morbidity of schizophrenia and depression of 43% and 35%, respectively, whether it was a primary reason for admission or a comorbid condition.
The results of this audit suggest that clinicians are aware of the available guidelines to perform testing on older patients that have a longer inpatient stay, p-value <0.001 and 0.017. However, the low rate of screening and replacement may be due to limited clinical guidelines and policies at an institutional level, and this has been suggested by Glendenning and Chew. 14 While there is a need for further studies to inform best practice, it is prudent to address this insufficiency and screening practices, especially in chronic mental illness.
Previous research has highlighted an inverse correlation between length of stay and vitamin D levels in a surgical sample. 15 The results found here are largely in line with this study, although the effect appears to be weak. This apparent attenuated relationship may be due to either differences in an inpatient psychiatric setting or a lack of statistical power as a result of poor vitamin D documentation. These results must be interpreted tentatively.
This study is observational in nature, thus the limitations extend to typical issues encountered in such studies. This includes medical record entries being dependent on accuracy and completeness. The findings are limited to a psychiatric unit in a public hospital. Similarly, there is a need to account for the ongoing discussion about optimal and target 25(OH)D concentrations, and variable and confusing reference intervals, with different measurement units used in research and practice. 
Conclusion
This study has reported the vitamin D screening inadequacy in an inpatient population within an Australian setting. It further highlighted the debate relating to benefit of testing and treating; however, while a low percentage of test ordering is being carried out, it is being ordered as per clinical judgement based on patient demographics. More research is recommended to establish tangible benefits of supplementation, while local practice provides valuable data for education and policy purposes.
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